慢性高原病的发病机制、诊断及治疗进展
Progress in Pathogenesis, Diagnosis and Treatment of Chronic Mountain Sickness
DOI: 10.12677/ACM.2022.124433, PDF,  被引量   
作者: 罗秀勇：青海大学研究生院，青海 西宁；耿 惠*：青海大学附属医院血液科，青海 西宁
关键词: 慢性高原病；高原红细胞增多症；缺氧；Chronic Mountain Sickness； High Altitude Polycythemia； Hypoxia
摘要: 由于中国高速发展，国防建设和高原建设的需求，中国慢性高原病的防治、治疗问题越来越突出。慢性高原病(chronic mountain sickness, CMS)的发生机理相当复杂，防治方法也尚未取得统一，因此本章将就慢性高原病的发生机制、诊断与防治方法作一综述。
Abstract: Due to the rapid development of China, the demand of national defense construction and plateau construction, the prevention and treatment of chronic mountain sickness in China is becoming more and more prominent. The pathogenesis of chronic mountain sickness (CMS) is very complex, and the prevention and treatment methods have not been unified. Therefore, this chapter will review the pathogenesis diagnosis and prevention of chronic altitude sickness.
文章引用：罗秀勇, 耿惠. 慢性高原病的发病机制、诊断及治疗进展[J]. 临床医学进展, 2022, 12(4): 3005-3009. https://doi.org/10.12677/ACM.2022.124433

参考文献

[1] 国际高原医学会慢性高原病专家小组. 第六届国际高原医学和低氧生理学术大会颁布慢性高原病青海诊断标准[J]. 青海医学院学报, 2005, 26(1): 3-5.
[2] Pena, E., El Alam, S., Siques, P. and Brito, J. (2022) Oxidative Stress and Diseases Associated with High-Altitude Exposure. Antioxidants (Basel), 11, 267. [Google Scholar] [CrossRef] [PubMed]
[3] Yan, S.M., Resta, T.C. and Jernigan, N.L. (2020) Vasoconstrictor Mechanisms in Chronic Hypoxia-Induced Pulmonary Hypertension: Role of Oxidant Signaling. Antioxidants (Basel), 9, E999. [Google Scholar] [CrossRef] [PubMed]
[4] Aboyoussef, A.M., Abdel-Sattar, A.R., Abdel-Bakky, M.S., et al. (2021) Enoxaparin Prevents CXCL16/ADAM10- Mediated Cisplatin Renal Toxicity: Role of the Coagulation System and the Transcriptional Factor NF-κB. Life Sciences, 270, Article ID: 119120. [Google Scholar] [CrossRef] [PubMed]
[5] Bailey, D.M., Brugniaux, J.V., Filipponi, T., et al. (2019) Exaggerated Systemic Oxidative-Inflammatory-Nitrosative Stress in Chronic Mountain Sickness Is Associated with Cognitive Decline and Depression. The Journal of Physiology, 597, 611-629. [Google Scholar] [CrossRef] 
[6] Yi, H., et al. (2021) Serum Inflammatory Factor Profiles in the Pathogenesis of High-Altitude Polycythemia and Mechanisms of Acclimation to High Altitudes. Mediators of Inflammation, 2021, Article ID: 8844438. [Google Scholar] [CrossRef] [PubMed]
[7] Zhao, C., Li, Z., Ji, L., Ma, J., Ge, R.L. and Cui, S. (2017) PI3K-Akt Signal Transduction Molecules Maybe Involved in Downregulation of Erythroblasts Apoptosis and Perifosine Increased Its Apoptosis in Chronic Mountain Sickness. Medical Science Monitor, 23, 5637-5649. [Google Scholar] [CrossRef] 
[8] Obeng, E. (2021) Apoptosis (Programmed Cell Death) and Its Signals—A Review. Brazilian Journal of Biology, 81, 1133-1143. [Google Scholar] [CrossRef] [PubMed]
[9] Ma, J., Ji, L., Li, Z., et al. (2019) Downregulation of Intrinsic Apoptosis Pathway in Erythroblasts Contributes to Excessive Erythrocytosis of Chronic Mountain Sickness. Blood Cells, Molecules and Diseases, 76, 25-31. [Google Scholar] [CrossRef] [PubMed]
[10] Shi, Q.H., Wei, W., Ran, J.H., et al. (2015) Hydrogen Therapy Reduces Oxidative Stress-Associated Risks Following Acute and Chronic Exposure to High-Altitude Environment. Biomedical and Environmental Sciences, 28, 239-241.
[11] 马轶, 罗伟. 慢性高原病的最新治疗研究进展[J]. 中西医结合心血管病电子杂志, 2020, 8(35): 26+46.
[12] Villafuerte, F.C. and Corante, N. (2016) Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment. High Altitude Medicine & Biology, 17, 61-69. [Google Scholar] [CrossRef] [PubMed]
[13] Pichon, A., Connes, P., Quidu, P., et al. (2012) Acetazolamide and Chronic Hypoxia: Effects on Haemorheology and Pulmonary Haemodynamics. European Respiratory Journal, 40, 1401-1409. [Google Scholar] [CrossRef] [PubMed]
[14] 钱稚萍, 王慰. 血液稀释疗法辅以家庭氧疗治疗慢性高原病129例疗效观察[J]. 中外医学研究, 2011, 9(29): 118.

为你推荐